Aspirin Esomeprazole Chemoprevention Trial – EXtension Long-term Clinical Study: a cohort follow-up of a Phase III randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia

niversity College London Comprehensive Clinical Trials Unit (UCL CCTU)0 个研究点目标入组 1,587 人开始时间: 2023年5月22日最近更新: 2024年2月5日

适应症

试验速览

暂无简介。

•1. Participants recruited to the original AspECT trial
•2. AspECT participants who have signed an AspECT-EXceL consent form or have the use of personal data covered by another access agreement
•3. Participants who have given consent to allow access to AspECT data or have access covered by another access agreement

•1. Participants who are alive and unable or unwilling to give consent to participate in AspECT ExceL and whose personal data is not covered by any other data access agreement
•2. Participants unwilling to give consent to allow access to AspECT data and are not covered by any other data access agreement
•3. Participants not included in the original AspECT trial

发起方

niversity College London Comprehensive Clinical Trials Unit (UCL CCTU)